SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001104659-23-104356
Filing Date
2023-09-27
Accepted
2023-09-27 17:26:26
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B4 tm2324931-9_424b4.htm 424B4 746804
2 GRAPHIC lg_transcodetheraptm-4c.jpg GRAPHIC 22504
3 GRAPHIC fc_therapeutic-4c.jpg GRAPHIC 200023
4 GRAPHIC tb_currentpipeline-4clr.jpg GRAPHIC 103020
  Complete submission text file 0001104659-23-104356.txt   1194477
Mailing Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109
Business Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109 857-301-6857
Transcode Therapeutics, Inc. (Filer) CIK: 0001829635 (see all company filings)

IRS No.: 811065054 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-274251 | Film No.: 231285539
SIC: 2834 Pharmaceutical Preparations